haematology
Blood cancers

Transformed lymphomas have excellent outcomes with rituximab

Patients with transformed lymphomas treated with rituximab have excellent survival outcomes without autologous stem cell transplantation consolidation (ASCT), Victorian clinicians say. A retrospective study of 45 lymphoma patients with histological transformation treated at the Department of Clinical Haematology, Monash Health, between 2002 and 2017 found that they had a five-year overall survival (OS) of 69% ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic